Related Experiment Videos
[Disseminated intravascular coagulation. II. Therapeutic problems]
Insights
Treating disseminated intravascular coagulation (DIC) is complex due to diagnostic challenges and rapid disease progression. Effective management requires addressing the underlying cause and employing anticoagulants, transfusions, and supportive care for improved outcomes.
Area of Science:
- Hematology
- Critical Care Medicine
Context:
- Disseminated intravascular coagulation (DIC) presents significant therapeutic challenges.
- Diagnosis is complicated by subtle symptoms and rapid disease progression.
- Management requires a multi-faceted approach addressing coagulation and organ support.
Purpose:
- To outline the complexities and essential components of managing disseminated intravascular coagulation (DIC).
- To emphasize the importance of prompt diagnosis and targeted therapy in DIC.
- To highlight the critical role of addressing both the coagulation cascade and systemic complications.
Summary:
- DIC treatment involves identifying and treating the trigger condition.
- Therapeutic strategies include anticoagulation with heparin to inhibit intravascular coagulation.
- Transfusional support with blood products and platelet concentrates is crucial for correcting consumption coagulopathy.
- Management also necessitates direct interventions for shock, cardiorespiratory compromise, and acute renal insufficiency.
- Successful outcomes depend on timely, individualized therapeutic interventions.
Impact:
- Optimizing DIC treatment protocols can improve patient survival rates.
- Understanding the pathophysiology guides rational therapeutic decision-making.
- Integrated care addressing both hematologic and organ system dysfunction is key to managing this critical illness.
Abstract:
The treatment of DIC often presents problems that are not easily solved given the difficulty of interpreting symptoms and haematological findings, the seriousness of the clinical situation and the rapid development of disease phenomena. Diagnostic questions must be answered before physiopathologically rational therapy can be applied. The identification and cure of the condition which triggers coagulation are also of primary importance in selecting a therapeutic response. Apart from specific treatment of the causal disease, the treatment of DIC is based on the one hand on the use of anticoagulants (heparin) to halt intravascular coagulation and transfusional integration with haemoderivatives and platelet concentrates to correct the haemostasis deficiency secondary to such massive consumption. On the other, direct methods are needed to control the state of shock, cardiorespiratory compromise and acute renal insufficiency which often complicate the course of the defibrination syndrome. Therapeutic success depends on timely intervention allied to the employment of adequate measures for each individual case.